| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.42 | 0.005 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.006 |